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Purpose: To evaluate the relationship between depressive
symptoms and health care costs in outpatients with chronic
medical illnesses in Korea, we screened for depressive
symptoms in 1,118 patients with a chronic medical illness and
compared the severity of somatic symptoms and health care
costs. Patients and Methods: Data were compared between
outpatients with depressive symptoms and those without
depressive symptoms. Depression and somatic symptoms were
measured by Zung's Self-rating Depression Scale (SDS) and
Patient Health Questionnaire (PHQ)-15, respectively. We also
investigated additional data related to patients' health care
costs (number of visited clinical departments, number of visits
made per patients, and health care costs). A total of 468
patients (41.9%) met the criteria for depressive disorder.
Results: A high rate of severe depressive symptoms was found
in elderly, female and less-educated patients. A positive
association between the severity of somatic symptoms and
depressive symptoms was also identified. The effects of
depressive symptoms in patients with chronic illnesses on
three measures of health services were assessed by controlling
for the effects of demographic variables and the severity of
somatic symptoms. We found that the effects of depressive
symptoms on the number of visited departments and number
of visits made per patients were mediated by the severity of
somatic symptoms. However, for health care costs, depressive
symptoms had a significant main effect. Furthermore, the
effect of gender on health care costs is moderated by the
degree of a patient's depressive symptoms. Conclusion: In
summary, there is clearly a need for increased recognition and
treatment of depressive symptoms in outpatients with chronic
medical illnesses.
Key Words: Depression symptoms, chronic medical illness,
somatic symptoms, health care costs
INTRODUCTION
Numerous studies have addressed the risks of
depression developing in patients with medical
illnesses. According to the World Health Organi-
zation (WHO) Collaborative Study,
1 depression
was 4.7 times more likely to develop in patients
with one chronic medical illness and 6 times more
likely in patients with two or more chronic
medical conditions than in normal, healthy
persons. Patients with rheumatoid arthritis,
2
asthma,
3 diabetes,
4-6 myocardial infarction,
7 and
cerebrovascular accident
8,9 have been shown to
have significantly more depressive symptoms.
The comorbidity of depression and medical
illness imposes an even greater burden on health
care services. Several studies have examined the
increase in the use of general medical services in
patients with specific chronic medical illnesses.
Included in this group were studies of patients
with heart failure,
10 diabetes
11 and arthritis.
12 These
studies reported that depression was associated
with increased use or cost of general medical
services. Also, depression in primary care
patients,
13-15 high utilizers of general medical
services,
16 and Medicare health maintenance
organization (HMO) patients
17 was associated
with a significant increase in overall health care
costs.
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Despite increased attention on the comorbidity
of depression and medical illness, little informa-
tion is available on the prevalence of depression
in Korean patients with chronic medical illnesses
and the ensuing economic burden it poses. The
present study firstly examined the prevalence of
depressive symptoms in outpatients with chronic
medical illnesses in Korea. Then, the associations
between depressive symptoms and demographic
characteristics were investigated. Furthermore,
since patients with depression frequently present
with somatic symptoms,
18 we additionally examined
the association between the depressive symptoms
and the severity of the somatic symptoms. Finally,
the effects of depressive symptoms in outpatients
with chronic medical illnesses on three measures
of health services (number of visited clinical
departments, number of visits made per patients,
and health care costs) were evaluated.
PATIENTS AND METHODS
Subjects were 1,534 consecutive outpatients
with chronic medical illnesses, aged 20 to 85, who
had been treated for at least one year in the
Department of Internal Medicine, St. Mary's
Hospital, The Catholic University of Korea. A
total of 1,254 patients participated in the study,
and 280 patients refused to participate (18.3%).
We excluded patients with a previous history of
psychiatric treatments from the study, because the
goal of the present study was to examine the health
care costs related to depressive symptoms alone.
We also excluded cancer patients because the
experience of cancer includes distinct chronological
phases, and research has repeatedly revealed a
higher prevalence of psychiatric illness in a
variety of populations of cancer patients than in
those with other medical illnesses.
19,20
Since patients with cancer and/or patients with
a previous history of psychiatric treatments were
excluded from the study, the data of 136 patients
were deleted from the sample, so the data of 1,118
patients were ultimately analyzed. Subjects were
relatively chronically ill patients who had been
treated for at least one year for endocrine diseases
(e.g. diabetes mellitus, thyroid disease; n = 195),
rheumatic diseases (e.g. rheumatoid arthritis,
systemic lupus erythematosus (SLE); n = 173),
gastrointestinal diseases (e.g. gastric ulcer, inflam-
matory bowel disease; n = 185), cardiovascular
diseases (e.g. hypertension, cardiac arrythmia; n =
196), renal diseases (e.g. chronic renal failure,
diabetic nephropathy; n = 184), or pulmonary
diseases (e.g. chronic obstructive pulmonary disease,
asthma; n = 185). Data were obtained by individual
interviews from February 2004 through June 2004.
Zung's Self-Rating Depression Scale (SDS) was
used to screen the patients for depressive sym-
ptoms.
21 The SDS is a self-rating scale containing
20 questions about depressive symptoms. We
used a Korean version of the SDS which was
translated by Shin et al.
22 Each item is anchored
on a 4-point scale (1 = no to 4 = always). In SDS,
an adjusted score of less than 49 points is
regarded as indicating a normal state, and 50 to
59 points, 60 to 69 points, and over 70 points
indicate mild, moderate, and severe depressive
symptoms, respectively.
22
The Patient Health Questionnaire somatic
symptom severity scale (PHQ-15) was used to
measure the severity of somatic symptoms in
subjects.
23 PHQ-15 is also a self-rating scale con-
taining 15 questions. All items are anchored on a
3-point scale (0 = no pain to 2 = severe pain). A
score of 0 to 4 points on the PHQ-15 indicates
minimal somatic symptom severity, and 5 to 9
points, 10 to 14 points, and 15 to 30 points
indicate low, medium and high somatic symptom
severities, respectively.
We also obtained additional data related to
patients' health care services during the year of
2003, including health care costs, number of
visited clinical departments, and number of visits
made per patients in any Korean hospital.
Computerized data were provided by the
National Health Insurance Corporation of Korea.
Written informed consent was obtained from all
subjects after a full description of the objectives
and procedures of the present study. The ethical
committee of St. Mary’s Hospital approved this
study.
The association between depressive symptoms
and somatic symptoms was analyzed by using the
Kruakal-Wallis one-way analysis of variance
(ANOVA). Statistical significances of the differences
in health care costs, numbers of visited clinicalDepression in Chronic Ill Patients and Health Care Costs
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departments, and the difference in numbers of
visits between patients with depressive symptoms
and those without any symptoms were assessed
by regressions which incorporated demographic
variables and the severity of somatic symptoms as
covariates. A p value < 0.05 was considered
statistically significant. All analyses were conducted
using SAS PC version 6.0.
RESULTS
Of the 1,118 patients with chronic medical
illnesses, 468 (41.9%) were categorized as having
significant depressive symptoms [242 mild
depression (21.6%), 142 had moderate depression
(12.7%), and 84 suffered from severe depression
(7.5%)]. Table 1 presents demographic information
for the four patient groups after stratification for
the severity of depressive symptoms, and it
includes patients without significant depressive
symptoms. Comparisons of demographics across
the four patient groups revealed that depressive
symptoms were associated with all demographic
data. In particular, the prevalence of mild depres-
sive symptoms was higher for younger patients,
while the prevalence of moderate or severe
depressive symptoms was higher for older pati-
ents (χ
2= 46.4, p < 0.001). Female patients were
also more likely to show depressive symptoms
than male patients (χ
2 = 49.1, p < 0.001). With
regard to education level, less educated patients
were more likely to develop moderate or severe
depressive symptoms (χ
2 = 67.9, p < 0.001). Finally,
patients who had endocrine diseases or cardio-
vascular diseases were more likely to show severe
depressive symptoms (χ
2 = 96.5, p < 0.001).
To evaluate the association between depressive
symptoms and somatic symptoms, we used a
Kruskal-Wallis one-way ANOVA to analyze the
severity of the somatic symptoms across four
groups (normal, mild, moderate, severe depres-
sion). Table 2 reveals that the severity of somatic
symptoms differed significantly across the four
Table 1. Demographic Characteristics and the Severity of Depressive Symptoms
Demographic characteristics
(n = 1118)
Normal
(n = 650)
Depressive symptoms
χ
2 p value Mild
(n = 242)
Moderate
(n = 142)
Severe
(n = 84)
Age (yrs) 20 - 29
30 - 39
40 - 49
50 - 59
60 - 69
70
48
109
175
250
314
222
24 (50%)
60 (55%)
102 (58%)
159 (64%)
190 (61%)
115 (52%)
17 (35%)
35 (32%)
46 (26%)
47 (19%)
60 (19%)
37 (17%)
6 (13%)
11 (10%)
21 (12%)
26 (10%)
38 (12%)
40 (18%)
1 ( 2%)
3 ( 3%)
6 ( 4%)
18 ( 7%)
26 ( 8%)
30 (13%)
46.4 < 0.001
Gender Female
Male
693
425
351 (51%)
299 (70%)
169 (24%)
73 (17%)
103 (15%)
39 ( 9%)
70 (10%)
14 ( 4%) 49.1 < 0.001
Education (yrs) None
1 - 6
7 - 9
10 - 12
13 - 16
17
50
182
169
331
328
58
15 (30%)
95 (52%)
99 (59%)
195 (59%)
203 (62%)
43 (74%)
11 (22%)
32 (18%)
36 (21%)
72 (22%)
81 (25%)
10 (17%)
12 (24%)
28 (15%)
21 (12%)
42 (13%)
34 (10%)
5 ( 9%)
12 (24%)
27 (15%)
13 ( 8%)
22 ( 6%)
10 ( 3%)
0 ( 0%)
67.9 < 0.001
Group CAD
PUL
END
REN
RHE
GI
196
185
195
184
173
185
88 (45%)
122 (66%)
121 (62%)
106 (58%)
87 (50%)
126 (68%)
37 (19%)
39 (21%)
31 (16%)
52 (28%)
49 (28%)
34 (18%)
36 (18%)
22 (12%)
16 ( 8%)
19 (10%)
29 (17%)
20 (11%)
35 (18%)
2 ( 1%)
27 (14%)
7 ( 4%)
8 ( 5%)
5 ( 3%)
96.5 < 0.001
CAD, cardiovascular disease; PUL, pulmonary disease; END, endocrine disease; REN, renal disease; RHE, rheumatic disease; GI,
gastrointestinal disease.Yu-Mi Na, et al.
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groups (χ
2 = 322.7, p < 0.001). The severe depressive
group showed significantly higher somatic sym-
ptoms than the mild and moderately depressive
groups. However, the mild and moderately
depressive groups had significantly higher somatic
symptoms than the normal controls.
Table 3 shows three measures of health services
according to the degree of depressive symptoms.
ANOVA results (Table 3) suggest strong evidence
for the association between depressive symptoms
and increased use of health services at all levels
of medical comorbidity (number of visited clinical
departments, F = 2.9, p = 0.032; number of visits
made per patients, F = 6.0, p < 0.001; healthcare
costs, F = 3.9, p = 0.009). Post-hoc analyses, which
are presented at the bottom of Table 3, display
homogeneous subsets for each dependent
variable. However, attention should be paid to
interpreting the results in Table 3, since, as we
have seen in Tables 1 and 2, depressive symptoms
were associated with demographic characteristics
and the severity of somatic symptoms. Therefore,
to appropriately assess the influence of depressive
symptoms on the use of health services, the effects
of demographic variables and the severity of
somatic symptoms should be controlled. Tables 4-
Table 2. Severity of Somatic Symptoms by Severity of Depressive Symptoms
Normal
(n = 650)
Depressive symptoms
χ
2 p value Mild
(n = 242)
Moderate
(n = 142)
Severe
(n = 84)
Severity of somatic symptoms 4.4 7.2 8.9 12.6 322.7* < 0.001
*Kruskal Wallis test statistics.
Table 3. Economic Burden by Severity of Depressive Symptoms
Normal
(n = 653)
Depressive symptoms
ANOVA
Results
p value Mild
(n = 245)
Moderate
(n = 144)
Severe
(n = 84)
Number of visited departments 4.17 4.15 4.31 4.75 F = 2.9 0.032
Number of visits 53.7 51.5 62.9 68.6 F = 6.0 < 0.001
Health care costs (thousand won) 2,283 2,747 2,856 3,492 F = 3.9 0.009
ANOVA with post hoc Duncan's Multiple Range Tests.
- Number of visited departments: normal=mild = moderate < severe depression.
- Number of visits: normal = mild < moderate = severe depression.
- Health care costs: normal = mild = moderate < severe depression.
Table 4. Regression Results for Number of Visited Depressive Symptoms
Unstandardized
coefficient
Std. error
Standardized
coefficient
T p value
(Constant) 2.669 0.410 6.52 0.000
Gender 0.408 0.116 0.112 3.52 0.000
Age 0.019 0.004 0.161 4.97 0.000
Education 0.002 0.013 0.005 0.146 0.884
Depressive symptoms - 0.004 0.006 - 0.026 - 0.701 0.483
Somatic symptoms 0.053 0.016 0.128 3.33 0.001Depression in Chronic Ill Patients and Health Care Costs
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6 present the results of regressions in which
demographic variables and the severity of somatic
symptoms were included as covariates.
The regression model for the number of visited
departments (Table 4) was significant (F = 13.8, p
< 0.001) and gender and age turned out to be
significant, as well. The number of visited
departments was greater for females and elderly
patients. Interestingly, the severity of somatic
symptoms was also significant, indicating that the
higher number of visited departments found in
the more depressed group of patients was due to
Table 5. Regression Result for Number of Visiting
Unstandardized
coefficient
Std. error
Standardized
coefficient
T p value
(Constant) 30.963 9.067 3.42 0.001
Gender 1.812 2.566 0.022 0.71 0.480
Age 0.473 0.089 0.171 5.33 0.000
Education - 0.903 0.298 - 0.102 - 3.04 0.002
Depressive symptoms - 0.005 0.137 - 0.001 - 0.04 0.970
Somatic symptoms 1.150 0.352 0.124 3.27 0.001
Table 6. Regression Results for Health Care Costs
(a) Main Effects Only
Unstandardized
coefficient
Std. error
Standardized
coefficient
T p value
(Constant) 16918.0 9853.5 1.77 0.078
Gender 12476.3 8064.0 0.174 1.55 0.122
Age - 30.0 80.4 - 0.012 - 0.37 0.709
Education - 791.4 270.2 - 0.101 -2.9 0.003
Depressive symptoms 529.0 182.2 - 0.164 2.9 0.004
Somatic symptoms 551.3 319.3 0.068 1.73 0.084
Gender*depressive symptoms - 490.6 208.2 - 0.303 - 2.36 0.019
(b) With Interaction Term (Gender*depressive symptoms)
Unstandardized
coefficient
Std. error
Standardized
coefficient
T p value
(Constant) 28517.6 8283.9 3.46 0.000
Gender - 5715.0 2331.3 - 0.079 - 2.45 0.014
Age - 35.7 80.5 - 0.015 - 0.444 0.657
Education - 790.0 270.8 - 0.101 - 2.92 0.004
Depressive symptoms 214.3 124.2 0.066 1.73 0.085
Somatic symptoms 514.9 319.6 0.063 1.61 0.107Yu-Mi Na, et al.
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the more severe somatic symptoms in these
groups. This relationship was repeated in the
regression model for number of visits made per
patients (Table 5; F = 19.8, p < 0.001). In Table 5,
age and education turned out to be significant.
The number of visits made per patients was
greater for the elderly and the less-educated.
Again, the severity of somatic symptoms was also
significant, revealing the mediating role of the
severity of somatic symptoms between depressive
symptoms and number of visits made per
patients. Standardized coefficients (Beta) in Table
5 indicate that age (Beta = 0.198) and the severity
of somatic symptoms were more important
variables in predicting patients' numbers of visits.
In a regression model for health care costs
(Table 6), gender, education and depressive
symptoms (at α = 10%) were significant, while the
severity of somatic symptoms was not. Gender,
years of education and depressive symptoms were
associated with significant increases in health care
costs. We further investigated possible interac-
tions among independent variables. Interaction
terms were not significant for number of visited
departments or number of visits. However, for
health care costs, only the interaction between
gender and depressive symptoms was significant
(Table 6(b)), indicating that health care costs were
highest for female patients with depressive
symptoms.
DISCUSSION
This study revealed that the prevalence of
depressive symptoms in Korean patients with
chronic medical illnesses was high (41.9%). This
prevalence is consistent with that found in
previous research
1,24 which reported 54.9%, 51.3%,
39.0%, 35.1%, and 33.8% prevalence rates in
patients with cardiovascular diseases, rheumatic
diseases, endocrine diseases, respiratory diseases,
or gastrointestinal diseases, respectively.
For early diagnosis and treatment of patients
with depression, it is very important to know that
some patients with certain demographic
characteristics are more vulnerable to depression.
Previous studies have found that age,
25 gender
26
and marital status
27 are associated with depre-
ssion. This tendency is also maintained for Korean
patients with chronic medical illnesses. A high
prevalence rate of severe depressive symptoms
was found in elderly and female patients. In
addition, we found that the patients with less
education tended to show severe depressive
symptoms. This could be related to self-efficacy
issues. Francis et al.
28 reported that there was a
significant increase in patients’ self-efficacy and a
significant decrease in depression symptoms after
a one-year adult literacy program.
To evaluate the effects of depressive symptoms
on health care costs in patients with chronic
illnesses, three measures of health services
(number of visited clinical departments, number
of visits, and health care costs) were selected. The
major contribution of this study is that the effects
of depressive symptoms in patients with chronic
illness on three measures of health services were
assessed by controlling for the effects of
demographic variables and the severity of somatic
symptoms. We found that the effects of depressive
symptoms on the number of visited departments
and the number of visits were mediated by the
severity of somatic symptoms. However, for
health care costs, depressive symptoms had a
significant main effect, indicating that they are
associated with significant increases in health care
costs. Furthermore, there exists a significant
interaction between gender and depressive
symptoms. This interaction term can be interpreted
as a moderating effect of depressive symptoms on
health care costs. In other words, the effect of
gender on health care costs is moderated by the
degree of a patient's depressive symptoms, such
that the magnitude of the effect is greater when
a patient's depressive symptom is severe than it
is when he/she is normal.
However, this study had some limitations. The
socio-economic characteristics of patients, which
were not included in our analyses, can influence
their use of health care services. Depressive
symptoms can be caused by the severity of
chronic illness. Therefore, the degree of chronic
illness needs to be considered in future studies.
Other limitations of this study include a cross-
sectional design. We were not able to distinguish
somatic symptoms due to depressive symptoms
from somatic symptoms due to chronic medicalDepression in Chronic Ill Patients and Health Care Costs
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illnesses. We also did not examine the different
departments that patients visited. Visiting the
psychiatric department or other departments such
as the surgical department would reflect different
aspects of patients’ conditions. In addition, data
provided by the National Health Insurance
Corporation of Korea may not appropriately
reflect patients' use of health care services, since
patients with chronic illnesses, especially in the
case of rheumatic diseases, visit alternative
medicine or naturopathic doctors more often.
Moreover, this study included a single university
hospital in Seoul, Korea. Therefore, the results of
this study would not necessarily generalize to
other regions.
In summary, depression is frequently comorbid
with other medical conditions. Despite its high
prevalence, depression often goes undetected,
imposing an even greater burden on patients’
daily lives and on health care services. This study
showed that chronic illness patients with depres-
sive symptoms were more likely to incur severe
somatic symptoms, more clinical treatments and
higher health care costs than are patients without
depressive symptoms. Therefore, there is clearly a
need for increased recognition and treatment of
depression for Korean patients with chronic
medical illnesses.
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